Category Archives: USPTO Practice and Policy

USPTO Holds First Roundtable on “Subject Matter Eligibility Guidelines”

On November 14th, the PTO hosted a roundtable discussion in Alexandria on s. 101 issues in which both industry reps and practitioners were invited to dissect the current Office guidelines. The structure was unique as there were 33 invited speakers … Continue reading

Posted in Patent Eligible Subject Matter, USPTO Practice and Policy | 1 Comment

PTO Schedules s. 101 Roundtables

At 81 Fed. Reg. 71485, The PTO has scheduled two roundtables at the PTO to receive feedback from the IP community, particularly on the Examples that were promulgated in May. The first roundtable will be on November 14th from 1:00-5:00 … Continue reading

Posted in Patent Eligible Subject Matter, USPTO Practice and Policy | Leave a comment

USPTO Post-Prosecution Pilot Program Launches

A guest post from Edward Sandor, attorney at Schwegman. The Post-Prosecution Pilot Program (P3) launched at the USPTO Monday, combining features of the AFCP 2.0 and Pre-Appeal Brief Conference Pilot programs, with the notable addition of Applicant participation in the process. … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , | Leave a comment

USPTO will “Fast Track” Cancer Immunotherapy Applications

On June 29, 2016, Director Lee promulgated rules to implement a one-year pilot program to effectively grant “Fast Track” status to applications with at least one claim to treating cancer using immunotherapy. (A copy of this document can be found … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , , , | Leave a comment